Abbott Laboratories
ABT
$107.28
Share price
1.91%
Change (1 day)
-4.46%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Revenue for Abbott Laboratories (ABT)
Revenue in 2023 (TTM): $40.10 B
According to Abbott Laboratories's latest financial reports the company's current revenue (TTM) is $40.10 B. In 2022 the company made a revenue of $43.65 B an increase over the years 2021 revenue that were of $43.07 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Abbott Laboratories from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $40.10 B | -8.12% |
| 2022 | $43.65 B | 1.34% |
| 2021 | $43.07 B | 24.47% |
| 2020 | $34.60 B | 8.48% |
| 2019 | $31.90 B | 4.34% |
| 2018 | $30.57 B | 11.64% |
| 2017 | $27.39 B | 31.35% |
| 2016 | $20.85 B | 2.2% |
| 2015 | $20.40 B | 1.11% |
| 2014 | $20.18 B | -5.27% |
| 2013 | $21.30 B | -20.21% |
| 2012 | $26.69 B | -31.28% |
| 2011 | $38.85 B | 10.48% |
| 2010 | $35.16 B | 14.31% |
| 2009 | $30.76 B | 4.19% |
| 2008 | $29.52 B | 13.94% |
| 2007 | $25.91 B | 18.47% |
| 2006 | $21.87 B | -2.08% |
| 2005 | $22.33 B | 13.51% |
| 2004 | $19.68 B | 6.46% |
| 2003 | $18.48 B | 4.53% |
| 2002 | $17.68 B | 8.59% |
| 2001 | $16.28 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | 131.92% | 🇺🇸 USA |
 Novartis NVS | $51.01 B | 27.18% | 🇨🇭 Switzerland |
 Pfizer PFE | $58.49 B | 45.85% | 🇺🇸 USA |
 Medtronic MDT | $32.32 B | -19.42% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $42.85 B | 6.85% | 🇺🇸 USA |
 Boston Scientific BSX | $14.24 B | -64.50% | 🇺🇸 USA |
 Hologic HOLX | $3.96 B | -90.10% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $45.00 B | 12.21% | 🇺🇸 USA |
 AstraZeneca AZN | $45.81 B | 14.22% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $37.84 B | -5.63% | 🇬🇧 UK |